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Abstract A ternary complex comprised of SRF, ternary com- 
plex factor (TCF) and the c-fos SRE is the target of several 
extracellular signal regulated pathways. Phosphorylation of the 
TCF Elk-1 is a key event in the activation of this complex. We 
demonstrate that ERK2/p42 phosphorylation of Elk-1 stimulates 
its recruitment into ternary complexes with SRF. Moreover, 
phosphorylation of Elk-1 also stimulates its autonomous SRF- 
independent binding to high affinity binding sites. Thus part of the 
effect of ERK2/p42 phosphorylation isto stimulate DNA-binding 
by the ETS DNA-binding domain of Elk-1. 
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I. Introduction 
Extracellular growth factors cause the rapid and transient 
transcriptional induction of the c-fos gene. These signals are 
transduced in part through the serum response lement SRE 
within the c-Jos promoter [1]. A ternary complex assembles at 
this site both in vivo and in vitro that contains two protein 
components, the serum response factor (SRF) and ternary 
complex factor (TCF) [1,2]. 
The TCFs represent a sub-group of the ETS-domain tran- 
scription factor family [3,4] that is comprised of at least 3 
members, Elk-1 [5], SAP1 [6], and SAP2/ERP/Net [6-8]. The 
TCFs utilise both protein/protein a d protein/DNA contacts 
to bind to the binary SRF/SRE complex. Three domains in the 
TCFs have been identified on the basis of primary sequence 
similarity; the N-terminal ETS-domain, which is involved in 
DNA-binding [6,9,10]; the B-domain which mediates direct 
contacts with SRF [11] and is required for ternary complex 
formation [6,9]; and the C-terminal domain which is the target 
for MAP kinases [12-14]. Indeed, extracellular signals are 
transduced via the MAP kinase pathway through the TCF 
component of this ternary complex [2,15]. Phosphorylation by
MAP kinase of TCFs purified from nuclear extracts causes an 
induction of their binding to SRF/SRE complexes [16]. This 
stimulation of binding activity is also observed using purified 
Elk-1 and p44/ERK1 [17]. In contrast, others have observed a
change in mobility of the ternary complex following MAP ki- 
nase phosphorylation f Elk-1 [12,13]. Furthermore phospho- 
rylation of the C-terminal domain of Elk-1 by MAP kinase 
causes an increase in its transcriptional ctivation properties 
[12,14]. In this study, we investigated the effect of p42/ERK2 
phosphorylation purified Elk-1. We show that recruitment 
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of Elk-1 into a ternary complex with SRF is stimulated by its 
phosphorylation by p42/ERK2 MAP kinase. Moreover, we 
also demonstrate that the phosphorylated form of Elk-1 shows 
enhanced autonomous binding to a site containing a high affin- 
ity ets- motif. These results indicate that at least part of the 
function of p42/ERK2 phosphorylation f Elk-1 is to stimulate 
the binding of the ETS-domain to DNA. 
2. Materials and methods 
2.1. Gel retardation analysis 
DNA binding reactions were carried out essentially as described 
previously [18] for 20 rain at room temperature in the presence of 125 
mM KCI. Proteins were bound to either the c-fos SRE or the Drosophila 
E74 site [11]. The protein/DNA complexes and free DNAs were re- 
solved by electrophoresis through 5% polyacrylamide g ls cast in 
1 x Tris-borate-EDTA (TBE) buffer. 
2.2. Prote& production 
The DNA-binding domain of SRF (core sRF) was purified from E. coli 
as described previously [11]. Full-length non-phosphorylated Elk-1 
(amino acids 1428) was purified as a C-terminally histidine-tagged 
protein from E. coil transformed with the plasmid pQE6/16Elk as 
described elsewhere [17]. MAP kinase (p42/ERK2) was expressed asa 
fusion with GST (GST : p42 MAPK) and purified from E. eoli by a modi- 
fication of the procedure described by Smith and Johnson [19]. Cells 
were lysed and GST:p42 MAPK was bound to reduced glutathione-aga- 
rose beads in 50 mM Tris-Cl, pH 7.4, 150 mM NaC1, 1 mM PMSF, 
1 mM DTT. Beads were washed in the same buffer and the purified 
GST:p42 MAPK was eluted in 100 mM HEPES, pH 8, 15 mM 
reduced glutathione. Finally, the purified GST:p42 MApK was dialysed 
against 20 mM HEPES, pH 8, 20% glycerol, 0.2 mM EDTA, 0.1 M 
KC1, 0.5 mM PMSF, 0.5 mM DTT. Active MEK (MAP kinase kinase) 
was partially purified from rat L6 cell extracts on a Mono-Q column 
using FPLC (Pharmacia). 
Phosphorylation f Elk-I by MAP kinase was carried out in 25/tl 
reaction mixtures containing ~4 ng GST:p42 ~APK, 1/~1 MEK extract, 
0.1 mM ATE 0.1 mM sodium vanadate, 40 mM Tris-C1 pH 7.4, 1 mM 
DTT, 10 mM MgC12, 10 ,uCi D,-32p]ATP, ~ 10 ng bacterially expressed 
Elk-1. Reactions were allowed to proceed for I h at 30°C. The presence 
of ATE MEK and MAP kinase was required for maximal stimulation 
of Elk-1 phosphorylation. 25 x MAP kinase inhibitor buffer (MIB) was 
50 mM EDTA [12], 20 x Phosphatase inhibitor buffer (PIB) was 20 mM 
sodium vanadate, 200 mM pNPP, 200 mM fl-glycerophosphate [16]. 
0.04 units of potato acid phosphatase (Boehringer-Mannheim) were 
added where indicated. 
3. Results 
Purified MAP kinase (ERK2/p42) preparations phospho- 
rylate TCFs purified from nuclear extracts and induce their 
recruitment into ternary complexes with SRF and the c-fos 
SRE [16]. We investigated whether the same effect could be 
brought about in vitro using purified components. The DNA 
binding domain of SRF (core sRF) was expressed in E. coli as 
a GST fusion protein and subsequently purified in the absence 
of the GST moiety [11]. Full-length Elk-I was purified from 
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Elk-1 utilises both protein-protein interactions [11] and pro- 
tein-DNA interactions [9,20] to bind specifically to the c-fos 
SRE. One or both of these interactions might be stimulated by 
MAP kinase phosphorylation f Elk-1. Although Elk-1 cannot 
bind autonomously to the c-los SRE, it can bind to other higher 
affinity sites that contain ets-motifs such as the Drosophila E74 
site [9,10,20]. We therefore took advantage of this observation 
to investigate the effect phosphorylation f Elk-1 has on its 
DNA-binding activity. Maximal DNA binding of both 
phosphorylated and non-phosphorylated Elk-1 to the E74 site 
occurs within 30 s of probe addition (data not shown). This 
rapid attainment ofequilibrium is indicative of a rapid on-rate. 
However, differences in the DNA binding affinity were appar- 
ent. Elk-1 that had been pre-phosphorylated by ERK2/p42 
MAP kinase, bound to the E74 site (Fig. 2, lane 1; closed 
arrow). However, the omission of either the MAP kinase (Fig. 
2, lane 2), the MEK (Fig. 2, lane 3) or ATP (Fig. 2, lane 5) 
caused a marked reduction in the binding of Elk-1. The inclu- 
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Fig. 1. ERK2/p42 phosphorylation f Elk-1 stimulates its recruitment 
into ternary complexes with SRF and the c-fos SRE. Elk-1 was pre- 
treated in the presence of the components indicated above each lane. 
The following components were omitted; GST MAP kinase (lane 2), 
MEK extract (lane 3), Elk-1 (lane 4), ATP (lane 5). MAP kinase inhib- 
itor buffer (MIB) was included in lane 6, Phosphatase inhibitor buffer 
(PIB) was included in lane 8. Potato acid phosphatase was included in 
lanes 7 and 8. Elk-1 was subsequently bound to SRF and 32p-labelled 
SRE. The mobilities of the binary (2 °) SRF:SRE and ternary (3 °) 
Elk : SRF: SRE complexes are indicated. 
E. coli using a hexa-histidine C-terminal tag [17]. ERK2/p42 
MAP kinase was purified in an inactive form as a GST fusion 
protein from E. coli. Activation of GST-ERK2 was carried out 
in vitro using extracts containing active MEK. Purified Elk-1 
was phosphorylated in vitro using the coupled MEK/GST- 
ERK2 system. Subsequently, the ability of the TCF Elk-1 to 
form ternary complexes was monitored using the gel retarda- 
tion assay in the presence of core sRv and a 32p-labelled SRE 
probe. Under these conditions Elk-1 forms a discrete ternary 
complex (Fig. 1, lanes 1 and 9). The function of this ternary 
complex is dependent upon the inclusion of Elk-1 in the binding 
reaction (Fig. 1, lane 4). However, if either the MAP kinase 
(Fig. 1, lane 2), MEK (Fig. 1, lane 3) or ATP (Fig. 1, lane 5) 
are omitted from the pre-incubation reaction, the recruitment 
of Elk-1 into the ternary complex is clearly reduced. Moreover, 
the inclusion of MAP kinase inhibitor buffer (MIB) (Fig. 1, lane 
6) also reduces ternary complex formation. Potato acid phos- 
phatase (PAP) reverses the effect of MAP kinase phosphoryla- 
tion (Fig. 1, lane 7) whereas the inclusion of phosphatase inhib- 
itor buffer (PIB) blocks this reversal (Fig. 1, lane 8). These data 
clearly demonstrate hat phosphorylation f Elk-1 by ERK2/ 
p42 MAP kinase stimulates its recruitment into ternary com- 
plexes with SRF and the SRE. 
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Fig. 2. ERK2/p42 phosphorylation f Elk-1 stimulates it  autonomous 
DNA binding to high affinity ETS-sites. Elk-1 was pre-treated in the 
presence of the components indicated above ach lane. The following 
components were omitted; GST MAP kinase (lane 2), MEK extract 
(lane 3), Elk-I (lane 4), ATP (lane 5). MAP kinase inhibitor buffer 
(MIB) was included in lane 6. Elk-1 was subsequently bound to a 
32p-labelled E74 site. The mobilities of fulMength Elk-1/E74 complexes 
are indicated by a closed arrow. The DNA-protein complex indicated 
by an open arrow probably represents a degradation product of Elk-l. 
The level of binding of this complex does not fluctuate in a phosphoryl- 
ation-dependent manner. 
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Fig. 3. Model depicting possible mechanisms whereby ERK2/p42 phos- 
phorylation of Elk-1/TCF stimulates its DNA-binding activity. In the 
non-phosphorylated state, EIk-1/TCF exists in a closed conformation. 
Upon phosphorylation f the C-domain by ERK2/p42 MAP kinase, 
Elk-I reverts to an open conformation i  which the ETS-domain and 
B-domain become accessible to the DNA and SRF, respectively. Elk-1 
can then subsequently bind either autonomously to ETS-motifs to form 
a binary complex or in conjunction with SRF to the SRE to form a 
ternary complex. 
sion of MAP kinase inhibitor buffer also blocked the stimula- 
tion of Elk-1 binding (Fig. 2, lane 6). These results essentially 
mirror those observed with the recruitment of Elk-1 into the 
ternary complex and indicate that ERK2/p42 phosphorylation 
of Elk-1 stimulates DNA-protein interactions by the Elk-1 ETS 
DNA-binding domain. A second faster mobility complex is also 
observed in the tracks containing Elk-l. The mobility of this 
complex is consistent with that of a truncated version of Elk-1 
(Elkl-168) which lacks the regulatory C-terminal domain and 
binds constitutively to the E74 site [11]. This complex is there- 
fore likely to represent a proteolytic degradation product of 
Elk-l. The intensity of this complex does not vary in manner 
that is consistent with a phosphorylation-dependent induction 
of DNA binding and is variable in different experiments. 
4. Discussion 
The phosphorylation of TCFs correlates with the rapid in- 
duction of c-fos transcription [15,16,21]. This is therefore a
pivotal step in the transduction of extracellular signals into a 
nuclear esponse. Several groups have proposed that a change 
in ternary complex mobility observed following phosphoryla- 
tion of Elk-1 reflects the induction of a large conformational 
change in this complex [12,19]. The majority of this effect is 
apparently mediated through the protein components rather 
than a change in DNA conformation (our unpublished ata). 
However, others have observed a clear phosphorylation-de- 
pendent stimulation of TCF/Elk-1 recruitment into a ternary 
complex with SRF and the SRE [16,22]. 
We demonstrate, using purified components, that ERK2/p42 
MAP kinase phosphorylation f Elk-1 stimulates the formation 
of ternary complexes with SRF and the SRE. This is consistent 
with recent work that shows that ERK1/p44 MAP kinase also 
induces imilar changes in the properties of Elk-1. Thus at least 
two MAP kinase isoforms cause similar alterations in the bio- 
chemical properties of Elk-1. It is possible that other more 
divergent members of the MAP kinase family may target and 
elicit similar effects on Elk-1. 
TCFs utilise both protein-protein and protein-DNA con- 
tacts to bind to the binary SRF/SRE complex [9,11,23]. Exper- 
iments in which the ETS-domain of Elk-1 is replaced with the 
heterologous DNA-binding domain of GAL4 suggest that it is 
the protein-protein interaction component that is stimulated by 
MAP kinase phosphorylation [14,17]. However, such experi- 
ments might underscore the importance of the ETS DNA- 
binding domain in regulating such interactions. Indeed we 
clearly demonstrate hat SRF-independent autonomous bind- 
ing of Elk-1 to DNA is enhanced by ERK2/p42 phosphoryla- 
tion. This implies that the stimulation of binding is via an 
enhancement of the ETS-domain:DNA interactions. Moreo- 
ver, clear differences in DNA-binding specificity of the ETS- 
domains of different TCFs have been identified (our unpub- 
lished data), suggesting a possible wider role of the ETS-do- 
main in determining target specificity. It is therefore likely that 
both protein-DNA and protein-protein i teractions mediated 
by Elk-1 are stimulated by MAP kinase phosphorylation. 
Our data are consistent with the model presented in Fig. 3. 
This is a refinement of the grappling hook model [24]. In the 
absence of phosphorylation, TCF/EIk-1 exists in a closed con- 
formation in which the accessibility of the B-domain and ETS- 
domain to SRF and DNA, respectively, are blocked (closed 
conformation). Phosphorylation of the C-domain of Elk-I by 
MAP kinases ubsequently induces aconformational change in 
which the protein-DNA and protein-protein i terfaces are ex- 
posed (open conformation) to allow recruitment of Elk-1/TCF 
to high affinity ETS-motifs or SRF:SRE complexes. Such pu- 
tative conformational changes have been inferred by others 
[12,13]. Moreover, the changes in mobility of binary and ter- 
nary complexes containing Elk-1 after phosphorylation (visible 
upon overexposure of Figs. 1 and 2) are also suggestive of 
phosphorylation induced conformational changes in TCF/Elk- 
1. Further experiments are required to formally prove the exis- 
tence of such putative phosphorylation-dependent co forma- 
tional changes in Elk-l. 
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